The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs seen on nocamels.com
A study by GrayMatters Health (opens in a new tab), which develops digital training therapies to help the brain regulate mental health care, has shown that its FDA-approved Prism device is effective in the treatment of post-traumatic stress disorder (PTSD).
The device, now available in selected clinics in the US, shows a patient’s brain activity in the amygdala, the small region of the brain associated with emotions and memory, while interacting with different scenarios.
This can help patients with PTSD control their symptoms by better understanding what triggers that heightened activity in that part of the brain.
GrayMatters Health Cofounders CEO and President Oded Kraft and VP R&D Shai Attia are both Technion alumni.